Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

ClinicalTrials.gov ID: NCT07667803

Public ClinicalTrials.gov record NCT07667803. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Oct 17, 2026, 1:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Master Protocol to Evaluate the Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus (Embold)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This master study protocol, Study D7260C00015, covers 2 independent, pivotal studies, Study 1 and Study 2. Each study is a global, randomized, double-blind, parallel-group, multicenter, Phase III study to assess the efficacy and safety of elecoglipron compared with placebo adjunct to diet and exercise for weight management, in adults living with obesity or overweight with at least one weight-related comorbidity, and without T2DM (Study 1) or with T2DM (Study 2).

Study identification

NCT ID
NCT07667803
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
4,500 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2026 (Actual)
Primary completion
Jul 31, 2028 (Estimated)
Completion
Jul 30, 2029 (Estimated)
Last update posted
Oct 13, 2026

2026 – 2029

United States locations

U.S. sites
56
U.S. states
34
U.S. cities
56
Facility City State ZIP Site status
Research Site Birmingham Alabama 35205 Recruiting
Research Site Dothan Alabama 36305 Recruiting
Research Site Chandler Arizona 85225 Recruiting
Research Site Sun City Arizona 85373 Not yet recruiting
Research Site Little Rock Arkansas 72205 Recruiting
Research Site Lynwood California 90262 Recruiting
Research Site Rolling Hills Estates California 90274 Recruiting
Research Site Sacramento California 95821 Recruiting
Research Site Arvada Colorado 80002 Recruiting
Research Site New Haven Connecticut 06519 Not yet recruiting
Research Site Plantation Florida 33324 Not yet recruiting
Research Site Tampa Florida 33606 Recruiting
Research Site Woodstock Georgia 30189 Recruiting
Research Site Ammon Idaho 83406 Recruiting
Research Site Melrose Park Illinois 60160 Recruiting
Research Site Indianapolis Indiana 46254 Recruiting
Research Site Wichita Kansas 67218 Recruiting
Research Site Louisville Kentucky 40213 Recruiting
Research Site Alexandria Louisiana 71303 Recruiting
Research Site Baltimore Maryland 21229 Not yet recruiting
Research Site Potomac Maryland 20854 Recruiting
Research Site White Marsh Maryland 21162 Recruiting
Research Site Ypsilanti Michigan 48197 Withdrawn
Research Site Ridgeland Mississippi 39157 Recruiting
Research Site Kansas City Missouri 64114 Recruiting
Research Site St Louis Missouri 63123 Recruiting
Research Site Reno Nevada 89511 Not yet recruiting
Research Site Albuquerque New Mexico 87106 Recruiting
Research Site Albany New York 12205 Not yet recruiting
Research Site Laurelton New York 11413 Recruiting
Research Site Long Island City New York 11106 Recruiting
Research Site Greensboro North Carolina 27408 Recruiting
Research Site Raleigh North Carolina 27609 Recruiting
Research Site Rocky Mount North Carolina 27804 Recruiting
Research Site Statesville North Carolina 28625 Recruiting
Research Site Columbus Ohio 43228 Recruiting
Research Site Dayton Ohio 45424 Recruiting
Research Site Oklahoma City Oklahoma 73134 Recruiting
Research Site Tulsa Oklahoma 74133 Recruiting
Research Site Portland Oregon 97223 Not yet recruiting
Research Site DuBois Pennsylvania 15801 Recruiting
Research Site Newport Pennsylvania 17074 Recruiting
Research Site Philadelphia Pennsylvania 19104 Not yet recruiting
Research Site East Providence Rhode Island 02914 Not yet recruiting
Research Site Charleston South Carolina 29407 Recruiting
Research Site Gaffney South Carolina 29340 Recruiting
Research Site Rapid City South Dakota 57701 Not yet recruiting
Research Site Franklin Tennessee 37067 Recruiting
Research Site Knoxville Tennessee 37912 Recruiting
Research Site Dallas Texas 75254 Recruiting
Research Site Houston Texas 77081 Recruiting
Research Site Humble Texas 77346 Recruiting
Research Site Irving Texas 75063 Recruiting
Research Site Sandy City Utah 84070 Not yet recruiting
Research Site Midlothian Virginia 23112 Recruiting
Research Site Morgantown West Virginia 26501 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 269 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07667803, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 13, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07667803 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →